The potential role of GLP-1 receptor agonists in substance use disorders - a systematic review. [PDF]
Völker KM +3 more
europepmc +1 more source
Integrating GLP-1 Receptor Agonists into Modern Stroke Prevention: Evidence, Mechanisms, and Clinical Consideration-A Narrative Review. [PDF]
Khan S +6 more
europepmc +1 more source
Global uptake of GLP-1 receptor agonists in obese, non-diabetic patients with cardiovascular disease. [PDF]
Chi KY +12 more
europepmc +1 more source
The effect of GLP-1 receptor agonists on renal outcomes: a systematic review and meta-analysis. [PDF]
Sasaki T +6 more
europepmc +1 more source
GLP-1 receptor agonists and risk of all cause and cause specific acute pancreatitis: target trial emulation. [PDF]
Xie Y, Choi T, Al-Aly Z.
europepmc +1 more source
Combining GLP-1 Receptor Agonists and SGLT2 Inhibitors for Cardiorenal Prevention: Evidence From Randomized Outcomes Trials. [PDF]
Gerstein HC, Sattar N.
europepmc +1 more source
Distilling the evidence for GLP-1 receptor agonists in alcohol use disorder. [PDF]
Bernstein EY, Schacht JP.
europepmc +1 more source
Efficacy of GLP-1 receptor agonists in Parkinson's disease: a systematic review and exploratory network meta-analysis of randomized controlled trials. [PDF]
Ali M +9 more
europepmc +1 more source

